![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Moribe Kunikazu Nomizu Natsuko Izukura Shunsuke Yamamoto Keiji Tozuka Yuichi Sakurai Manabu Ishida Atsushi Nishida Hirofumi Miyazaki Masaru
Publisher: Informa Healthcare
ISSN: 1083-7450
Source: Pharmaceutical Development and Technology, Vol.13, Iss.6, 2008-11, pp. : 541-547
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Moyer J.A. Wood A. Zaleska M.M. Ay I. Finklestein S.P. Protter A.A.
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 11, 1998-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic utilities of fibroblast growth factor 19
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Effects of basic fibroblast growth factor on central nervous system functions
Pharmacological Research, Vol. 43, Iss. 4, 2001-04 ,pp. :